July 01, 2013
Pfizer Inc. launched a series of patent infringement suits Friday in Delaware federal court against Amneal Pharmaceuticals LLC, Impax Laboratories and other generic-drug manufacturers for seeking approval for their own versions of Pfizer's overactive-bladder medication Toviaz.